The store will not work correctly when cookies are disabled.
4-(5-nitrofuran-2-yl)-5-phenylpyrimidine
ID: ALA4075521
PubChem CID: 137652492
Max Phase: Preclinical
Molecular Formula: C14H9N3O3
Molecular Weight: 267.24
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=[N+]([O-])c1ccc(-c2ncncc2-c2ccccc2)o1
Standard InChI: InChI=1S/C14H9N3O3/c18-17(19)13-7-6-12(20-13)14-11(8-15-9-16-14)10-4-2-1-3-5-10/h1-9H
Standard InChI Key: WZYVBNDFKZEVAI-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
2.1860 -10.0745 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1849 -10.8941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8929 -11.3030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6026 -10.8936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5997 -10.0709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8911 -9.6657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3119 -11.3032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3986 -12.1157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1982 -12.2844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6058 -11.5760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0579 -10.9697 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4217 -11.4901 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7529 -10.7430 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9031 -12.1505 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3029 -9.6610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0124 -10.0686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7181 -9.6580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7155 -8.8400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0012 -8.4342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2985 -8.8471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 1 0
4 7 1 0
12 13 2 0
12 14 1 0
10 12 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
5 15 1 0
M CHG 2 12 1 14 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 267.24 | Molecular Weight (Monoisotopic): 267.0644 | AlogP: 3.31 | #Rotatable Bonds: 3 |
Polar Surface Area: 82.06 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.29 | CX LogP: 2.82 | CX LogD: 2.82 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.54 | Np Likeness Score: -1.10 |
References
1. Verbitskiy EV, Baskakova SA, Gerasimova NA, Evstigneeva NP, Zil'berberg NV, Kungurov NV, Kravchenko MA, Skornyakov SN, Pervova MG, Rusinov GL, Chupakhin ON, Charushin VN.. (2017) Synthesis and biological evaluation of novel 5-aryl-4-(5-nitrofuran-2-yl)-pyrimidines as potential anti-bacterial agents., 27 (13): [PMID:28512023] [10.1016/j.bmcl.2017.05.013] |